ESR1 and Familial prostate cancer: Interestingly, for all the three independent datasets analyzed, an enrichment of up- and down-regulated transcriptional targets for both AR and ESR1 emerged, suggesting a possible interplay between these two proteins in controlling the neuroendocrine transdifferentiation process of prostate cancer (Supplementary Table S6).